Literature DB >> 31287962

Exploring the link between diabetes and pancreatic cancer.

Margherita Pizzato1, Federica Turati1, Valentina Rosato2, Carlo La Vecchia1.   

Abstract

Introduction: Epidemiological studies indicate an association between type 2 diabetes and pancreatic cancer but the complex and multidirectional relationship between them remains unclear. Areas covered: We summarized epidemiological evidence on diabetes and pancreatic cancer exploring the time-risk relationship. We described mechanisms linking long-standing diabetes to pancreatic cancer. We discussed pancreatic cancer-associated diabetes and its implication in the early detection of pancreatic cancer. Expert opinion: The markedly increased risk of pancreatic cancer in patients with new-onset diabetes compared with long-standing diabetes observed in several epidemiological studies indicates a complex and bidirectional connection, with long-standing diabetes being a predisposing factor for pancreatic cancer (increasing the risk of the malignancy 1.5- to 2-fold) and new-onset diabetes an early manifestation of the tumor. Identifying clinical features and biomarkers to distinguish pancreatic cancer-associated diabetes from type 2 diabetes is an important goal to improve management and survival of this cancer. Imaging (MRI) for middle-age patients with new-onset diabetes may be considered.

Entities:  

Keywords:  Pancreatic cancer; review; type 2 diabetes; type 3c diabetes

Mesh:

Substances:

Year:  2019        PMID: 31287962     DOI: 10.1080/14737140.2019.1642109

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  6 in total

1.  Trends of cancer mortality in Xi'an City, China: 2005-2020.

Authors:  Ning Chen; Xiao-Yu Zhang; Lin-Lin Ma; Guo-Dong Zhao; Yu-Xiang Yan
Journal:  J Cancer Res Clin Oncol       Date:  2022-05-14       Impact factor: 4.322

2.  Risk Factors of Pancreatic Cancer in Patients With Type 2 Diabetes Mellitus: The Hong Kong Diabetes Study.

Authors:  Raymond Ngai Chiu Chan; Teddy Tai Loy Lee; Oscar Hou In Chou; Jenny So; Cheuk To Chung; Edward Christopher Dee; Kenrick Ng; Pias Tang; Leonardo Roever; Tong Liu; Wing Tak Wong; Gary Tse; Sharen Lee
Journal:  J Endocr Soc       Date:  2022-09-05

3.  Diabetes Mellitus and Pancreatic Ductal Adenocarcinoma-Prevalence, Clinicopathological Variables, and Clinical Outcomes.

Authors:  Anna Badowska-Kozakiewicz; Marta Fudalej; Daria Kwaśniewska; Marek Durlik; Anna Nasierowska-Guttmejer; Agata Mormul; Emilia Włoszek; Aleksandra Czerw; Tomasz Banaś; Andrzej Deptała
Journal:  Cancers (Basel)       Date:  2022-06-08       Impact factor: 6.575

Review 4.  Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects.

Authors:  Silviu Stanciu; Florentina Ionita-Radu; Constantin Stefani; Daniela Miricescu; Iulia-Ioana Stanescu-Spinu; Maria Greabu; Alexandra Ripszky Totan; Mariana Jinga
Journal:  Int J Mol Sci       Date:  2022-09-04       Impact factor: 6.208

Review 5.  Diabetes mellitus and endometrial carcinoma: Risk factors and etiological links.

Authors:  Ya Wang; Xinling Zeng; Jie Tan; Yi Xu; Cunjian Yi
Journal:  Medicine (Baltimore)       Date:  2022-08-26       Impact factor: 1.817

6.  Diabetes risk reduction diet and the risk of pancreatic cancer.

Authors:  Federica Turati; Marta Rossi; Veronica Mattioli; Francesca Bravi; Eva Negri; Carlo La Vecchia
Journal:  Eur J Nutr       Date:  2021-08-02       Impact factor: 5.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.